Mohamed Tausif Siddiqui1, Mohammad Bilal2, Lakshmi Asritha Gollapudi3, Dhruv Mehta3, Shifa Umar4, Jonathan Barsa3, Christopher Nabors5, Beth Schorr-Lesnick3, Edward Lebovics3, Virendra Tewari3. 1. Department of Internal Medicine, New York Medical College, Valhalla, NY, 10595, USA. dr_tausifsiddiqui@yahoo.com. 2. Division of Gastroenterology and Hepatology, University of Texas Medical Branch, Galveston, TX, 77555, USA. 3. Department of Gastroenterology, New York Medical College, Valhalla, NY, 10595, USA. 4. Division of Gastroenterology, Hepatology and Nutrition, Allegheny Health Network, Pittsburgh, PA, 15212, USA. 5. Department of Internal Medicine, New York Medical College, Valhalla, NY, 10595, USA.
Abstract
BACKGROUND: Gastrointestinal hemorrhage (GIH) is reported to occur in 1-8% of patients admitted with acute ischemic stroke (AIS). AIS is considered to be a relative contraindication to GIE. AIMS: Evaluate the outcomes of gastrointestinal endoscopy (GIE) in patients hospitalized with AIS and GIH. METHODS: Patients hospitalized with AIS and GIH were included from the National Inpatient Sample 2005-2014. Primary outcome measure was in-hospital mortality in patients with AIS and GIH who underwent gastrointestinal endoscopy. Secondary outcomes were (1) resource utilization as measured by length of stay (LOS) and total hospitalization costs and (2) to identify independent predictors of undergoing GIE in patients with AIS and GIH. Confounders were adjusted for by using multivariable regression analysis. RESULTS: A total of 75,756 hospitalizations were included in the analysis. Using a multivariate analysis, the in-hospital mortality was significantly lower in patients who underwent GIE as compared to those who did not [aOR: 0.4, P < 0.001]. Patients who underwent GIE also had significantly shorter adjusted mean LOS [adjusted mean difference in LOS: 0.587 days, P < 0.001]. Patients with AIS and GIH who did not undergo GIE had significantly higher adjusted total hospitalization costs. [Mean adjusted difference in total hospitalization costs was $5801 (P < 0.001).] Independent predictors of undergoing GIE in this population were male gender, age > 65 years, Asian or Pacific race, hypovolemic shock, need for blood transfusion and admission to urban non-teaching hospital. CONCLUSIONS: Gastrointestinal endoscopy can be safely performed in a substantial number of patients with AIS and GIH.
BACKGROUND:Gastrointestinal hemorrhage (GIH) is reported to occur in 1-8% of patients admitted with acute ischemic stroke (AIS). AIS is considered to be a relative contraindication to GIE. AIMS: Evaluate the outcomes of gastrointestinal endoscopy (GIE) in patients hospitalized with AIS and GIH. METHODS:Patients hospitalized with AIS and GIH were included from the National Inpatient Sample 2005-2014. Primary outcome measure was in-hospital mortality in patients with AIS and GIH who underwent gastrointestinal endoscopy. Secondary outcomes were (1) resource utilization as measured by length of stay (LOS) and total hospitalization costs and (2) to identify independent predictors of undergoing GIE in patients with AIS and GIH. Confounders were adjusted for by using multivariable regression analysis. RESULTS: A total of 75,756 hospitalizations were included in the analysis. Using a multivariate analysis, the in-hospital mortality was significantly lower in patients who underwent GIE as compared to those who did not [aOR: 0.4, P < 0.001]. Patients who underwent GIE also had significantly shorter adjusted mean LOS [adjusted mean difference in LOS: 0.587 days, P < 0.001]. Patients with AIS and GIH who did not undergo GIE had significantly higher adjusted total hospitalization costs. [Mean adjusted difference in total hospitalization costs was $5801 (P < 0.001).] Independent predictors of undergoing GIE in this population were male gender, age > 65 years, Asian or Pacific race, hypovolemic shock, need for blood transfusion and admission to urban non-teaching hospital. CONCLUSIONS: Gastrointestinal endoscopy can be safely performed in a substantial number of patients with AIS and GIH.
Authors: Dayna S Early; Tamir Ben-Menachem; G Anton Decker; John A Evans; Robert D Fanelli; Deborah A Fisher; Norio Fukami; Joo Ha Hwang; Rajeev Jain; Terry L Jue; Khalid M Khan; Phyllis M Malpas; John T Maple; Ravi S Sharaf; Jason A Dominitz; Brooks D Cash Journal: Gastrointest Endosc Date: 2012-06 Impact factor: 9.427
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: M J O'Donnell; M K Kapral; J Fang; G Saposnik; J W Eikelboom; W Oczkowski; J Silva; L Gould; C D'Uva; F L Silver Journal: Neurology Date: 2008-08-06 Impact factor: 9.910
Authors: Sushil K Garg; Chimaobi Anugwom; James Campbell; Vaibhav Wadhwa; Nancy Gupta; Rocio Lopez; Sukhman Shergill; Madhusudhan R Sanaka Journal: Endosc Int Open Date: 2017-05